α4β1 integrin blockade after spinal cord injury decreases damage and improves neurological function
Jennifer C. Fleming(Western University), Lynne C. Weaver(Robarts Clinical Trials), Jane K. Relton(Biogen (United States)), Eilis F. Hamilton(Robarts Clinical Trials), Yuhua Chen(Xi'an Peihua University), Feng Bao(Robarts Clinical Trials)
Cited by 64
Related Papers
Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage after Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function
|Journal of Neuroscience|2004|319
Effects of post-weld heat treatment on the microstructure and mechanical properties of laser-welded NiTi/304SS joint with Ni filler
|Materials Science and Engineering A|2019|272
Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo
|Journal of Neuroinflammation|2018|191
Antibody to the α4 Integrin Decreases Infarct Size in Transient Focal Cerebral Ischemia in Rats
|Stroke|2001|167
Early anti‐inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats
|Journal of Neurochemistry|2004|159